|Bid||0.78 x 0|
|Ask||0.79 x 0|
|Day's Range||0.7600 - 0.7900|
|52 Week Range||0.6800 - 1.6200|
|Beta (3Y Monthly)||17.05|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.29|
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that its strategic international partner, ICC International Cannabis Corp. ("ICC") (CSE:WRLD), has entered into a definitive agreement to acquire all of the issued and outstanding shares of Green Gene Research Inc. (“Green Gene”), a cannabis genetics company with significant experience in cannabis research, testing, cultivation and the optimization of proprietary seeds and strains. In addition, Green Gene controls a portfolio of over 120 laboratory-tested unique cannabis strains carefully curated over the past 17 years of Green Gene’s operations. In connection with the strategic investment and commercial rights agreement announced on September 17, 2018, Auxly has become a preferred commercial partner to ICC on its current and future international and domestic cannabis ventures, including Green Gene, for a period of 10 years.
Auxly Cannabis Group Inc. (TSX.V - XLY) (CBWTF) ("Auxly" or the "Company") has reported its financial and operational results for the three and nine months ended September 30th, 2018. Auxly’s management team has prioritized the following objectives for each of the Company’s business segments. Upstream: The Company continues to acquire cultivation capacity through the development of facilities in Canada and Uruguay.
Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") is pleased to announce that, further to the binding interim agreement announced on January 30th, 2018, the Company has received approval from the Secretaría Nacional para la Lucha contra el Lavado de Activos y el Financiamiento del Terrorismo (“SENACLAFT”), the government body overseeing foreign direct investments in Uruguay, for the Company’s acquisition of 80% of the issued and outstanding common shares (the “Transaction”) of Inverell S.A. (“Inverell”). Inverell is a federally licensed Cannabis Operator based in Montevideo, Uruguay. Led by Dr. Raúl Urbina, Inverell is a large-scale outdoor producer of hemp plants for CBD extraction operating on an initial footprint of approximately 300 hectares.
Atlantic was founded by a team with a long-standing commitment to building opportunities in the province of Newfoundland and Labrador. Pillars of local industry, Christopher J. Hickman, Tom Collingwood Sr., Cynthia Crosbie and the entire Atlantic team lend to the project decades of unparalleled strategic leadership and oversight from diverse business environments. Atlantic’s collective of entrepreneurs have employed thousands of people across the province throughout the last five generations and look forward to playing a key role in the growth of the province's legal cannabis industry.
CALGARY , Sept. 21, 2018 /CNW/ - High Tide Ventures Inc. ("High Tide" or the "Company") today announced that it congratulates FSD Pharma Inc. (CSE:HUGE) ("FSD Pharma") for achieving a $1 Billion market capitalization and its other recent successes. The Company would like to commend FSD Pharma on reaching such a significant valuation milestone in the Canadian cannabis market, which only a small number of other companies have been able to achieve. Further, High Tide would also like to acknowledge the significance of FSD Pharma's recent receipt of $7.5 Million from Auxly Cannabis Group Inc. (XLY.V) ("Auxly"), at a premium to its recent market share price, to further fund construction of its 220,000 square foot cultivation facility in Cobourg, Ontario .
Pursuant to the Transaction, Auxly has subscribed for $7,500,000 of publicly traded Class B Subordinate Voting Shares of FSD at a price of $1.00 per share (“Purchased Shares”). Proceeds from the financing will be used to fund the ongoing construction of the initial 220,000 square feet of cultivation space that Auxly and FSD are jointly developing at FSD’s 620,000 square foot facility (the “Facility”) in Cobourg, Ontario pursuant to the agreed upon construction and development budget, announced on July 3, 2018. Auxly retains a 49.9% stream of all cannabis and cannabis-derived products produced at the Facility, under partnership with Auxly, in perpetuity.
TORONTO , Sept. 20, 2018 /CNW/ - FSD Pharma Inc. ("FSD" or the "Company") (HUGE.CN) is pleased to announce that pursuant to the approved construction and development budget announced on July 3, 2018 (Link), Auxly Cannabis Group Inc. (TSX.V – XLY) ("Auxly") has made an equity investment into the Company at $1.00 per Class B Subordinate Voting Share for total proceeds of $7.5 million . The buildout of the Joint Cultivation Footprint is currently underway in Cobourg, Ontario and will include dedicated space for large scale extraction capabilities. In addition to the Joint Cultivation Footprint, FSD is also implementing several technological advancements at the Cobourg facility aimed at increasing energy efficiency and post-harvest process automation.
Auxly Cannabis Group Inc. (XLY.V) (CBWTF) ("Auxly" or the "Company") and Kaneh Bosm BioTechnology Inc. (CSE:KBB)(8K51.F)(KNHBF) ("Kaneh Bosm") are pleased to announce that Auxly has completed a strategic investment (the “Investment”) and has entered into a commercial rights agreement (the “Agreement” and together with the Investment, the “Transaction”) with Kaneh Bosm. Kaneh Bosm, through its subsidiaries, has a number of agreements and licences in place related to pharmaceutical distribution, wholesale importation, research and development, cultivation, production, storage, and exportation of cannabis and cannabis derivatives. In particular, Kaneh Bosm has agreements in place to supply a European-based pharmaceutical distributor with a network of 35,000 pharmacies in 16 countries, in addition to working interests in industrial hemp licences in Greece and wholly-owned licences to cultivate, produce, distribute, store, and export cannabis in Colombia, the Kingdom of Lesotho, and Denmark.
CORAL GABLES, FL / ACCESSWIRE / September 11, 2018 / Canadian marijuana stocks continue to lead the sector as the October deadline looms. In roughly 1 month Canada will begin legal sale of recreational marijuana across the country but this is just the beginning for the country. The move by Canada effectively makes the country the first G7 nation to legalize recreational cannabis use and further opens opportunities for companies in Canada to export marijuana as well.
CALGARY , Aug. 30, 2018 /CNW/ - Inner Spirit Holdings Ltd. ("Inner Spirit" or "the Company") (ISH.CN), a specialty retailer and franchisor establishing recreational cannabis dispensaries across Canada under the Spiritleaf brand, today announced the filing of its financial statements and management's discussion and analysis for the second quarter ended June 30, 2018 . The filings are available for review under Inner Spirit's SEDAR www.sedar.com and CSE profiles. "The closing of our IPO and our strategic partnership agreements have strengthened our balance sheet as well as our position in Canada's recreational cannabis market," said Darren Bondar, President & CEO.
CALGARY , July 31, 2018 /CNW/ - Inner Spirit Holdings Ltd. ("Inner Spirit" or "the Company"), is pleased to announce that it has closed its initial public offering (the "IPO"). The Company closed on the maximum gross proceeds under the IPO of $3,750,000 and issued 25,000,000 units of Inner Spirit (the "Units"). Each Unit consists of one common share in the capital of the Company (each, a "Common Share") and one-half of one Common Share purchase warrant (each whole Common Share purchase warrant, a "Unit Warrant").
CALGARY , July 30, 2018 /CNW/ - High Tide Ventures Inc. ("High Tide" or the "Company") today announced that it has recently entered into multiple non-binding memorandums of understanding ("MOUs") to supply the Saskatchewan market on a wholesale basis for a combined total of up to 9,500 kilograms of cannabis products over the next year, as available. High Tide is in the process of becoming a licensed wholesaler of cannabis products in the province of Saskatchewan . The MOUs are with FV Pharma Inc. ("FV Pharma"), Maple Leaf Green World Inc. ("Maple Leaf"), Sundial Growers Inc. ("Sundial") and The Supreme Cannabis Company, Inc. ("Supreme").